Research Program Term. Except as otherwise provided herein, the Research Program Term shall commence on the Effective Date and continue for a period of one (1) year (the "Initial Research Program Term"). Merck may, in its sole discretion, extend the Research Program Term for an additional one (1) year period by providing Metabasis with written notice of such election at least sixty (60) days prior to the first anniversary of the Effective Date and in the event of such election by Merck the Parties shall in good faith agree upon any necessary amendments to the Research Plan, as applicable, including, without limitation, the number of Metabasis FTEs to be committed and funded by Merck for such extended term. Thereafter, the Parties may extend the Research Program Term by mutual written agreement of the authorized representative of the Parties, and shall, in such case, amend the *** Confidential Treatment Requested Research Plan as applicable. Each of the foregoing extensions of the Research Program Term shall be referred to herein as an "Extended Research Program Term."
Appears in 3 contracts
Sources: Exclusive License and Research Collaboration Agreement (Metabasis Therapeutics Inc), Exclusive License and Research Collaboration Agreement (Metabasis Therapeutics Inc), Exclusive License and Research Collaboration Agreement (Metabasis Therapeutics Inc)